Catus Consult ApS: Financial statements 2025
CVR: 39791633
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Catus Consult ApS (CVR 39791633) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 680,675 and a net result of DKK 137,824 compared with DKK -7,234 the year before. Equity in the 2025 report amounted to DKK 181,118. The solvency ratio was 71%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 680,675
- Profit/Loss
- DKK 137,824
- Equity
- DKK 181,118
- Total Assets
- DKK 255,078
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 681 t. | 138 t. | 181 t. | 1 |
| 2024 | - | -9 t. | -7 t. | 43 t. | 0 |
| 2023 | - | - | 0 | 40 t. | - |
| 2022 | - | - | 0 | 40 t. | - |
| 2021 | - | 0 | 0 | 40 t. | - |
Official annual report
How creditworthy is Catus Consult ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Catus Consult ApS has published its annual report for 2024. Gross profit came to DKK -9,400, and the net result was DKK -7,234.
On January 1, 2025, the company changed its name from Isanans Pharma ApS to Catus Consult ApS.
About Catus Consult ApS
Catus Consult ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Isanans Pharma ApS and Isanans Pharma IVS. The management consists of Kamilla Rolsted. The company is owned by VAMI Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 680,675 and a net result of DKK 137,824 compared with DKK -7,234 the year before. Equity in the 2025 report amounted to DKK 181,118.